Bloomberg Daybreak: Asia Edition cover image

Trump Says He'll Set Unilateral Tariffs; China's Biotech Boom

Bloomberg Daybreak: Asia Edition

00:00

Pharmaceutical Partnerships in China

This chapter examines recent licensing agreements between major pharmaceutical companies and Chinese biotech firms, focusing on significant deals like Pfizer's with 3SBio. It also discusses the state of the biotech industry amid a downturn in funding, the impact of economic policies on pharma profitability, and the promising growth of China's biotech labor market.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app